Amrize (NYSE:AMRZ) Stock Price Expected to Rise, UBS Group Analyst Says

by · The Markets Daily

Amrize (NYSE:AMRZ – Get Free Report) had its price target lifted by equities research analysts at UBS Group from $53.00 to $57.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price points to a potential upside of 3.91% from the stock’s current price.

A number of other equities analysts have also recently commented on AMRZ. Weiss Ratings restated a “hold (c+)” rating on shares of Amrize in a report on Monday, December 29th. Sanford C. Bernstein reissued an “outperform” rating and set a $70.00 price target on shares of Amrize in a research report on Thursday, December 18th. Wells Fargo & Company lifted their price objective on shares of Amrize from $57.00 to $58.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Vertical Research assumed coverage on shares of Amrize in a research note on Tuesday, November 25th. They set a “hold” rating and a $54.00 target price on the stock. Finally, Kepler Capital Markets raised shares of Amrize to a “strong-buy” rating in a research report on Tuesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $60.36.

Get Our Latest Stock Report on Amrize

Amrize Trading Up 0.8%

Amrize stock traded up $0.42 during trading on Thursday, hitting $54.86. The company had a trading volume of 1,181,868 shares, compared to its average volume of 2,195,704. Amrize has a 1-year low of $44.12 and a 1-year high of $57.40. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38. The company has a 50 day simple moving average of $52.47. The stock has a market cap of $30.34 billion and a PE ratio of 29.79.

Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.03). The firm had revenue of $3.68 billion during the quarter, compared to analyst estimates of $3.49 billion. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year.

Insider Activity

In other news, Director Nicholas C. Gangestad acquired 2,000 shares of the firm’s stock in a transaction dated Wednesday, November 19th. The stock was acquired at an average cost of $47.34 per share, with a total value of $94,680.00. Following the transaction, the director owned 4,958 shares in the company, valued at approximately $234,711.72. This trade represents a 67.61% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CTO Roald Brouwer bought 4,000 shares of the stock in a transaction that occurred on Friday, October 31st. The shares were purchased at an average price of $51.77 per share, with a total value of $207,080.00. Following the purchase, the chief technology officer owned 9,000 shares of the company’s stock, valued at approximately $465,930. This represents a 80.00% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 65,000 shares of company stock valued at $3,399,720 over the last quarter.

Institutional Investors Weigh In On Amrize

Hedge funds and other institutional investors have recently made changes to their positions in the business. Grove Bank & Trust increased its position in Amrize by 48.0% in the 4th quarter. Grove Bank & Trust now owns 14,600 shares of the company’s stock valued at $790,000 after acquiring an additional 4,737 shares during the period. Nordea Investment Management AB acquired a new position in shares of Amrize during the fourth quarter worth about $26,517,000. Harbor Investment Advisory LLC purchased a new position in Amrize during the fourth quarter worth about $379,000. Cantor Fitzgerald L. P. boosted its holdings in Amrize by 51.4% in the 3rd quarter. Cantor Fitzgerald L. P. now owns 11,666 shares of the company’s stock valued at $566,000 after purchasing an additional 3,963 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new position in shares of Amrize during the 3rd quarter worth approximately $5,974,000.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading